Diabetes and Cancer A consensus report

被引：1690

作者：

Giovannucci, Edward ^{[1
]}

Harlan, David M. ^{[2
,3
,4
]}

Archer, Michael C. ^{[5
,6
]}

Bergenstal, Richard M. ^{[7
]}

Gapstur, Susan M. ^{[8
]}

Habel, Laurel A. ^{[9
]}

Pollak, Michael ^{[10
]}

Regensteiner, Judith G. ^{[11
]}

Yee, Douglas ^{[12
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Dept Nutr, Boston, MA 02115 USA

[2] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Diabet Ctr Excellence, Worcester, MA USA

[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA

[4] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA

[5] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada

[6] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada

[7] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA

[8] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA

[9] Kaiser Permanente, Div Res, Oakland, CA USA

[10] McGill Univ, Dept Oncol, Montreal, PQ, Canada

[11] Univ Colorado, Sch Med, Aurora, CO USA

[12] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA

来源：

DIABETES CARE | 2010年 / 33卷 / 07期

基金：

美国国家卫生研究院;

关键词：

ACTIVATED RECEPTOR-GAMMA; BODY-MASS INDEX; LIFE-STYLE INTERVENTION; BREAST-CANCER; INSULIN-RECEPTOR; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; PPAR-GAMMA; IGF-I; RISK;

D O I：

10.2337/dc10-0666

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and diabetes treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning 1) the association between diabetes and cancer incidence or prognosis, 2) risk factors common to both diabetes and cancer, 3) possible biologic links between diabetes and cancer risk, and 4) whether diabetes treatments influence risk of cancer or cancer prognosis. In addition, key unanswered questions for future research are posed.

引用

页码：1674 / 1685

页数：12

共 122 条

[11]

BERGENSTAL RM, 1918, AM J MED, V374, pE9

[12] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].

Bowker, SL ;

Majumdar, SR ;

Veugelers, P ;

Johnson, JA .

DIABETES CARE, 2006, 29 (02) :254-258

[13] Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis [J].

Buchwald, Henry ;

Estok, Rhonda ;

Fahrbach, Kyle ;

Banel, Deirdre ;

Jensen, Michael D. ;

Pories, Walter J. ;

Bantle, John P. ;

Sledge, Isabella .

AMERICAN JOURNAL OF MEDICINE, 2009, 122 (03) :248-U81

[14] Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study [J].

Burstein, HJ ;

Demetri, GD ;

Mueller, E ;

Sarraf, P ;

Spiegelman, BM ;

Winer, EP .

BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (03) :391-397

[15] Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia [J].

Butler, Peter C. .

DIABETES, 2009, 58 (11) :2427-2428

[16] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].

Calle, EE ;

Rodriguez, C ;

Walker-Thurmond, K ;

Thun, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638

[17] Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].

Calle, EE ;

Kaaks, R .

NATURE REVIEWS CANCER, 2004, 4 (08) :579-591

[18] Is it Time to Test Metformin in Breast Cancer Clinical Trials? [J].

Cazzaniga, Massimiliano ;

Bonanni, Bernardo ;

Guerrieri-Gonzaga, Aliana ;

Decensi, Andrea .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) :701-705

[19]

*CECP, 2008, NAT DIAB FACT SHEET

[20] 15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells [J].

Clay, CE ;

Monjazeb, A ;

Thorburn, J ;

Chilton, FH ;

High, KP .

JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1818-1828

← 1 2 3 4 5 6 7 8 9 10 →